Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of orthopedics, gynecology, pediatrics, cardiac, diabetic, derma-cosmetic, pain management, antibiotics, central nervous system, neuro, critical care, gastro-intestinal, and vitamins and nutrient products. The company also provides male and female infertility, energy and immunity boosting, protein supplement, arthritis and joint pain, hepatoprotective, haematinic, and pet care products, as well as herbal supplement, cosmetics, and hospital products. It offers its products in the form of tablets, capsules, soft gels, liquid orals, ointments/creams, solid formulations, sachets, lozenges, and cosmetics. In addition, the company provides contract manufacturing services. It also exports its products to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, and Myanmar. The company was incorporated in 2003 and is based in Pune, India.
Metrics to compare | CIAH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCIAHPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.5x | 10.9x | −0.5x | |
PEG Ratio | 0.00 | 0.15 | 0.00 | |
Price/Book | 0.2x | 1.3x | 2.6x | |
Price / LTM Sales | 0.2x | 1.5x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 8.9% | 7.1% | Unlock |